Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 22, 2023
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
Geulah Livshits Reiterated (CABA) at Strong Buy and Held Target at $12 on, Mar 22nd, 2023
Geulah Livshits of Chardan Capital, Reiterated "Cabaletta Bio, Inc." (CABA) at Strong Buy and Held Target at $12 on, Mar 22nd, 2023.
Geulah has made no other calls on CABA in the last 4 months.
There are 4 other peers that have a rating on CABA. Out of the 4 peers that are also analyzing CABA, 0 agree with Geulah's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Geulah
- Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $15 on, Friday, March 17th, 2023
- Uy Ear of "Mizuho" Reiterated at Strong Buy and Held Target at $10 on, Friday, March 17th, 2023
- Michael Ulz of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $16 on, Friday, January 27th, 2023
- Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $14 on, Tuesday, January 3rd, 2023
